Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Receivables (2020 - 2024)

Historic Receivables for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $13011.4 billion.

  • Universe Pharmaceuticals' Receivables rose 77.4% to $13011.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13011.4 billion, marking a year-over-year increase of 77.4%. This contributed to the annual value of $13011.4 billion for FY2025, which is 77.4% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Receivables of $13011.4 billion as of Q3 2025, which was up 77.4% from $12911.5 billion recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Receivables ranged from a high of $13011.4 billion in Q3 2025 and a low of $14.4 million during Q1 2024
  • In the last 5 years, Universe Pharmaceuticals' Receivables had a median value of $18.3 million in 2022 and averaged $3240.4 billion.
  • Data for Universe Pharmaceuticals' Receivables shows a peak YoY increase of 320706238.55% (in 2024) and a maximum YoY decrease of 1789.48% (in 2024) over the last 5 years.
  • Over the past 5 years, Universe Pharmaceuticals' Receivables (Quarter) stood at $16.3 million in 2021, then decreased by 1.73% to $16.0 million in 2022, then surged by 2419.97% to $402.6 million in 2023, then soared by 3207062.39% to $12911.5 billion in 2024, then rose by 0.77% to $13011.4 billion in 2025.
  • Its Receivables was $13011.4 billion in Q3 2025, compared to $12911.5 billion in Q3 2024 and $14.4 million in Q1 2024.